Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells

Carcinogenesis

Volumn 30, Issue 7, 2009, Pages 1234-1242

  Pan, Min Hsiung ^a   Chiou, Yi Siou ^a   Chen, Wei Jen ^b   Wang, Ju Ming ^c   Badmaev, Vladimir ^d   Ho, Chi Tang ^e  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d SABINSA CORPORATION   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PTEROSTILBENE; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN HEPG2; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE REPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSIENT TRANSFECTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER NEOPLASMS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; STILBENES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSPLANTATION, HETEROLOGOUS;

EID: 67650105291     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp121     Document Type: Article

References (43)

1. Remsberg,C.M. et al. (2008) Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother. Res. 22, 169-179.
2. Pan,M.H. et al. (2008) Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. J. Agric. Food Chem., 56, 7502-7509.
3. Bergsland,E.K. et al. (2000) Hepatocellular carcinoma. Curr. Opin. Oncol., 12, 357-361.
4. Izumi,R. et al. (1994) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106, 720-727.
5. Kilian,M. et al. (2006) Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: Inhibition of matrix metalloproteinases in pancreatic cancer. Prostaglandins Leukot. Essent. Fatty Acids, 75, 429-434.
6. Mizutani,K. et al. (2000) The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer. Surg. Today, 30, 614-621.
7. Gullu,I.H. et al. (2000) The relation of gelatinase (MMP-2 and -9) expression with distant site metastasis and tumour aggressiveness in colorectal cancer. Br. J. Cancer, 82, 249.
8. Yan,C. et al. (2007) Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol., 211, 19-26.
9. Donadio,A.C. et al. (2008) Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats. Histochem. Cell Biol., 130, 1155-1164.
10. Cortes-Reynosa,P. et al. (2008) Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol., 27, 220-231.
11. Okuducu,A.F. et al. (2006) Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. Histopathology, 48, 836-845.
12. Nee,L. et al. (2007) TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells. Nephron. Exp. Nephrol., 107, e73-e86.
13. Hollborn,M. et al. (2007) Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest. Ophthalmol. Vis. Sci., 48, 4360-4367.
14. Cowden Dahl,K.D. et al. (2008) Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res., 68, 4606-4613.
15. Zeisberg,M. et al. (2002) Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am. J. Pathol., 160, 2001-2008.
16. Lee,S.O. et al. (2008) Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem. Biophys. Res. Commun., 366, 1019-1024.
17. Lee,S.O. et al. (2007) Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem. Biophys. Res. Commun. 354, 165-171.
18. Cho,H.J. et al. (2007) Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis, 28, 1104-1110.
19. Griner,E.M. et al. (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer, 7, 281-294.
20. Zhang,S. et al. (2006) Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway. Mol. Cancer Ther., 5, 3285-3293.
21. Chung,T.W. et al. (2004) Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/ AKT pathways: Involvement of invasive potential. FASEB J., 18 1123-1125.
22. Chakraborti,S. et al. (2003) Regulation of matrix metalloproteinases: An overview. Mol. Cell. Biochem., 253, 269-285.
23. Simon,C. et al. (2001) The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res., 271, 344-355.
24. Guruvayoorappan,C. et al. (2008) Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol. Immunotoxicol., 30, 711-727.
25. Waas,E.T. et al. (2003) Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br. J. Surg., 90, 1556-1564.
26. Okada,N. et al. (2001) Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer. Biochem. Biophys. Res. Commun., 288, 212-216.
27. Pettit,G.R. et al. (2002) Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resverastatin phosphate. J. Med. Chem., 45, 2534-2542.
28. George,S.E. et al. (1997) Functional coupling of endogenous serotonin (5-HT1B) and calcitonin (C1a) receptors in CHO cells to a cyclic AMP-responsive luciferase reporter gene. J. Neurochem., 69, 1278-1285.
29. Kajanne,R. et al. (2007) EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J. Cell. Physiol., 212, 489-497.
30. Weng,C.J. et al. (2008) Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis, 29, 147-156.
31. Kikkawa,U. et al. (1983) Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem., 258 11442-11445.
32. Guo,K. et al. (2008) Role of PKCbeta in hepatocellular carcinoma cells migration and invasion in vitro: A potential therapeutic target. Clin. Exp. Metastasis, 26, 189-195.
33. Pan,M.H. et al. (2008) Chemopreventive effects of natural dietary compounds on cancer development. Chem. Soc. Rev., 37, 2558-2574.
34. Suh,N. et al. (2007) Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clin. Cancer Res., 13, 350-355.
35. Pan,M.H. et al. (2008) Food bioactives, apoptosis, and cancer. Mol. Nutr. Food Res., 52, 43-52.
36. Pan,M.H. et al. (2007) Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. J. Agric. Food Chem. 55, 7777-7785.
37. Ferrer,P. et al. (2005) Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia, 7, 37-47.
38. Murayama,K. et al. (2007) Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors. Oncogene, 26, 4882-4888.
39. Carpenter,C.L. et al. (1996) Phosphoinositide kinases. Curr. Opin. Cell Biol., 8, 153-158.
40. Chung,T.W. et al. (2004) Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J., 18, 1670-1681.
41. Woo,J.H. et al. (2004) Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene, 23, 1845-1853.
42. Garg,R. et al. (2008) Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin. Carcinogenesis, 29, 1249-1257.
43. Hunter,K.W. et al. (2008) Mechanisms of metastasis. Breast Cancer Res., 10 (suppl. 1), S2.